FarnesolAn inducer of apoptosis in cell cultures

Farnesol (CAS 4602-84-0)

Farnesol | CAS 4602-84-0 is rated 5.0 out of 5 by 1.
  • y_2019, m_12, d_7, h_14
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.3
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204748, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 101ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Application: An inducer of apoptosis in cell cultures
CAS Number: 4602-84-0
Purity: ≥97%
Molecular Weight: 222.37
Molecular Formula: C15H26O
Supplemental Information: This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
* Refer to Certificate of Analysis for lot specific data (including water content).
Submit a review for this product and receive 15 CruzCredits

Farnesol is a polyprenyl alcohol found in plant essential oils. Induces apoptosis in cell cultures.


References

Yaguchi M, Miyazawa K, Katagiri T et al. Leukemia. 11:779-87 (1997). Haug JS, Goldner CM, Yazlovitskaya EM et al. Biochim Biophys Acta. 1223:133-40 (1994).

Physical State :
Liquid
Solubility :
Soluble in 70% alcohol (1:13). Insoluble in water.
Storage :
Store at room temperature
Melting Point :
3.24° C (Predicted)
Boiling Point :
149° C (lit.) at 4 mmHg
Density :
0.89 g/mL at 20° C (lit.)
Refractive Index :
n20D 1.49 (lit.)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
WGK Germany :
3
RTECS :
JR4979000
PubChem CID :
3327
Merck Index :
14: 3937
MDL Number :
MFCD00002918
EC Number :
225-004-1
Beilstein Registry :
1763926
SMILES :
CC(=CCCC(=CCCC(=CCO)C)C)C

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Farnesol  Product Citations

See how others have used Farnesol. Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 9153192  Finder, JD. et al. 1997. J. Biol. Chem. 272: 13484-13488.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 152ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Finder Finder, JD. et al. (PubMed 9153192) used farensol to demonstrate that superinduction of nitric oxide synthase-2 in rat pulmonary artery smooth muscle cells and rat heptaocytes is not due to inhibition of farnesylation. -SCBT Publication Review
Date published: 2015-06-14
  • y_2019, m_12, d_7, h_14
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.3
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_204748, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 3ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2019 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.